Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

STRATA Skin Sciences (SSKN) Debt to Equity (2016 - 2025)

STRATA Skin Sciences' Debt to Equity history spans 13 years, with the latest figure at $5.28 for Q4 2025.

  • On a quarterly basis, Debt to Equity rose 72.74% to $5.28 in Q4 2025 year-over-year; TTM through Dec 2025 was $5.28, a 72.74% increase, with the full-year FY2025 number at $5.28, up 72.74% from a year prior.
  • Debt to Equity hit $5.28 in Q4 2025 for STRATA Skin Sciences, down from $11.65 in the prior quarter.
  • Over the last five years, Debt to Equity for SSKN hit a ceiling of $28.7 in Q2 2025 and a floor of $0.02 in Q2 2021.
  • Historically, Debt to Equity has averaged $3.2 across 5 years, with a median of $0.91 in 2023.
  • Biggest five-year swings in Debt to Equity: tumbled 79.47% in 2021 and later soared 1705.29% in 2025.
  • Tracing SSKN's Debt to Equity over 5 years: stood at $0.29 in 2021, then increased by 18.91% to $0.34 in 2022, then soared by 246.24% to $1.19 in 2023, then soared by 157.7% to $3.06 in 2024, then surged by 72.74% to $5.28 in 2025.
  • Business Quant data shows Debt to Equity for SSKN at $5.28 in Q4 2025, $11.65 in Q3 2025, and $28.7 in Q2 2025.